Presentation is loading. Please wait.

Presentation is loading. Please wait.

Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial  Prof Robert.

Similar presentations


Presentation on theme: "Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial  Prof Robert."— Presentation transcript:

1 Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial  Prof Robert S Heyderman, PhD, Prof Shabir A Madhi, PhD, Prof Neil French, PhD, Clare Cutland, MBBCh, Bagrey Ngwira, PhD, Doris Kayambo, MBBS, Robert Mboizi, MS, Anthonet Koen, MBBCh, Lisa Jose, MBBCh, Morounfolu Olugbosi, MD, Frederik Wittke, MD, Karen Slobod, MD, Peter M Dull, MD  The Lancet Infectious Diseases  Volume 16, Issue 5, Pages (May 2016) DOI: /S (15) Copyright © 2016 Heyderman et al. Open Access article distributed under the terms of CC BY Terms and Conditions

2 Figure Study profile Most participants who did not complete the study were from the Malawi site, with the exception of the two women who relocated: one woman in the high CD4 cell count group who was lost to follow-up after delivery and one infant in the high CD4 cell count group who died between birth and day 42. The Lancet Infectious Diseases  , DOI: ( /S (15) ) Copyright © 2016 Heyderman et al. Open Access article distributed under the terms of CC BY Terms and Conditions


Download ppt "Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial  Prof Robert."

Similar presentations


Ads by Google